Friday, October 26, 2012

[Ingigo Insight] New comment on New Adventure.

Anonymous has left a new comment on your post "New Adventure":

[url=http://www.pharma-vision.net #33][img]http://i50.tinypic.com/suzubt.png [/img][/url]
So, we've already established that Searle's clinical trials and the FDA's approval of Oxandrolone established it as a mild anabolic, designed to maintain and promote lean tissue growth or maintenance.
[url=http://www.pharma-vision.net #83]build muscle [/url]
We've also established that Oxandrolone is so mild in terms of its side effects that women and even children were included as subjects in the clinical trials, and that it was approved for their use as well.



Posted by Anonymous to Ingigo Insight at October 26, 2012 7:00 AM

No comments: